Chase AIPricingFAQs
Display currency
Loading news…

Kelonia Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Boston, Massachusetts, United States Founded 2017 11-50 employees For Profit

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Kelonia Therapeutics was acquired by Eli Lilly in 2026 for $7B.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
45
Patents
15
16 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Patents granted
15
Trademarks
16
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
IT spend
$147K

Company Info

Founded
2017
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
4
News articles
133
HQ
Boston, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded
Exit date
Apr 20, 2026

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.7
Trend (30d)
-2.9
Trend (90d)
8.6

Key People at Kelonia Therapeutics

Office Manager/HR Coordinator
Associate Scientist II
Director, LVV CMC
Scientist II
Chief Business Officer
Associate Director, T Cell Biology
Associate Scientist I
Co-Founder and Chief Executive Officer
Associate Scientist I
Vice President, HR
Co-Founder and Board Member
Principal Associate Scientist
Principal Associate Scientist
Senior Associate Scientist II
Principal Associate Scientist
Senior Manager, Facilities & Lab
Associate Scientist II
Vice President of Finance
Senior Director, Preclinical Sciences
45
professional contacts at Kelonia Therapeutics
Contact execs at Kelonia Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Kelonia Therapeutics

Loading news…

FAQs about Kelonia Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Kelonia Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments